DRMA Q1 2026 Earnings Narrower Loss Than Expected Bolsters Investor Sentiment IMMP Q1 2026 Earnings Earnings Miss Estimates as Clinical Expenses Weigh on Results ITGR Q1 2026 Earnings EPS Slightly Misses Estimates Amid Mixed Conditions Origin Materials ORGN Q4 2025 Earnings Massive EPS Miss Amid No Revenue Reported Stock Rises 268 TRNR Q4 2025 Earnings Significant EPS Miss Reflects Ongoing Challenges GSBC Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Decline